{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:59:39Z","timestamp":1791475179406,"version":"4.3.4"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Metabolic composite indices effectively predict type 2 diabetes mellitus (T2DM) in the general population. However, whether these indices retain predictive value in patients with nonalcoholic fatty liver disease (NAFLD)\u2014a population characterized by profound insulin resistance and metabolic heterogeneity\u2014remains unclear. This study aimed to compare the predictive ability of twelve metabolic composite indices for the onset of T2DM in the NAFLD population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a secondary analysis of 2,370 NAFLD patients from a prospective Japanese cohort. Multivariate Cox proportional hazards models, subgroup analyses, and restricted cubic spline (RCS) regression were used to evaluate the associations between the twelve metabolic composite indices and incident T2DM. Predictive performance was assessed using receiver operating characteristic (ROC) and area under the curve (AUC) analyses, with optimal cut-offs determined using Youden\u2019s index and validated by Kaplan\u2013Meier curves.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In the fully adjusted model, all twelve indices were significantly associated with new-onset T2DM. The triglyceride\u2013glucose\u2013waist circumference (TyG-WC) index exhibited the greatest increase in the hazard ratio (HR) per 1-standard deviation (SD) [HR: 1.80, 95% confidence interval (CI): 1.56\u20132.07], followed by the triglyceride\u2013glucose\u2013waist\u2013height ratio (TyG-WHtR) (HR: 1.77, 95% CI: 1.54\u20132.04) and the triglyceride\u2013glucose\u2013body\u2013mass index (TyG-BMI) (HR: 1.70, 95% CI: 1.47\u20131.96). Conversely, the visceral adiposity index (VAI) showed the weakest association (HR per 1-SD increase: 1.29; 95% CI: 1.15\u20131.42). All associations were linear (\n                      <jats:italic>P<\/jats:italic>\n                      for nonlinearity &amp;gt;0.05 for all indices), and subgroup analyses revealed no significant interactions (\n                      <jats:italic>P<\/jats:italic>\n                      for interactions &amp;gt;0.05 for all). Notably, the TyG-WHtR exhibited the highest predictive accuracy (AUC\u00a0=\u00a00.680; optimal cut-off: 4.54), although its discriminative ability was not statistically superior to that of the TyG-WC index (\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a00.492). Its discriminatory ability remained stable throughout the follow-up period, and AUC values ranged from 0.634 to 0.719.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>All the assessed metabolic composite indices are linearly associated with incident T2DM in NAFLD patients. The TyG-WHtR may serve as a practical tool for T2DM risk stratification in patients with NAFLD, given its moderate yet temporally consistent discriminatory ability and easily obtainable components.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1805902","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:18:14Z","timestamp":1777609094000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["TyG-WHtR predicts incident type 2 diabetes mellitus in NAFLD: a 12-year prospective cohort study"],"prefix":"10.3389","volume":"17","author":[{"given":"Nan\u2019nan","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Zibo Infectious Disease Hospital","place":["Zibo, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Affiliated Cardiovascular and Cerebrovascular Diseases Hospital of Yan\u2019an University","place":["Yan\u2019an, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, Zibo Infectious Disease Hospital","place":["Zibo, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faming","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, Zibo Infectious Disease Hospital","place":["Zibo, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1097\/hep.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"4","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2022.0239","article-title":"Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach","volume":"4","author":"Le","year":"2022","journal-title":"Clin Mol Hepatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30125","article-title":"Patient-reported outcomes and the economic effects of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: The value proposition","volume":"6","author":"Younossi","year":"2018","journal-title":"Hepatology"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-322786","article-title":"Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort","volume":"7","author":"Simon","year":"2021","journal-title":"Gut"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28785","article-title":"The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe","volume":"5","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: a multisystem disease","author":"Byrne","year":"2015","journal-title":"J Hepatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/s2468-1253(18)30077-3","article-title":"Non-alcoholic fatty liver disease and the interface between primary and secondary care","volume":"7","author":"Tsochatzis","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31173","article-title":"Changes in the global burden of chronic liver diseases from 2012 to 2017: The growing impact of NAFLD","volume":"5","author":"Paik","year":"2020","journal-title":"Hepatology"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.10.033","article-title":"Non-alcoholic fatty liver disease - a global public health perspective","volume":"3","author":"Younossi","year":"2019","journal-title":"J Hepatol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41575-021-00448-y","article-title":"The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments","volume":"9","author":"Targher","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-300342","article-title":"Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography","volume":"3","author":"Wong","year":"2012","journal-title":"Gut"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20466","article-title":"Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity","volume":"6","author":"Browning","year":"2004","journal-title":"Hepatology"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-309265","article-title":"Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study","volume":"8","author":"Kwok","year":"2016","journal-title":"Gut"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-1805","article-title":"Type 2 diabetes: etiology and reversibility","volume":"4","author":"Taylor","year":"2013","journal-title":"Diabetes Care"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1615439","article-title":"Diabetic foot ulcers and their recurrence","volume":"24","author":"Armstrong","year":"2017","journal-title":"N Engl J Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-8587(24)00242-0","article-title":"Younger-onset compared with later-onset type 2 diabetes: an analysis of the UK Prospective Diabetes Study (UKPDS) with up to 30 years of follow-up (UKPDS 92)","volume":"12","author":"Lin","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1001\/jama.2015.7008","article-title":"Association of cardiometabolic multimorbidity with mortality","volume":"1","author":"Di Angelantonio","year":"2015","journal-title":"Jama"},{"key":"B18","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","article-title":"Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis","volume":"2","author":"Vilar-Gomez","year":"2015","journal-title":"Gastroenterology"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/s41366-018-0076-3","article-title":"Ectopic fat obesity presents the greatest risk for incident type 2 diabetes: a population-based longitudinal study","volume":"1","author":"Okamura","year":"2019","journal-title":"Int J Obes (Lond)"},{"key":"B20","doi-asserted-by":"publisher","first-page":"112398","DOI":"10.1016\/j.diabres.2025.112398","article-title":"Triglyceride glucose-waist height ratio index is a promising and robust glucose and lipid metabolism indicator for predicting long-term type 2 diabetes: insights from a Japanese prospective cohort data from 12 years","volume":"227","author":"Dou","year":"2025","journal-title":"Diabetes Res Clin Pract"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.862919","article-title":"Predictive effect of triglyceride glucose-related parameters, obesity indices, and lipid ratios for diabetes in a Chinese population: a prospective cohort study","volume":"13","author":"Li","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1331739","article-title":"Obesity- and lipid-related indices as a predictor of type 2 diabetes in a national cohort study","volume":"14","author":"Wang","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B23","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12902-025-01989-y","article-title":"Triglyceride glucose-weight-adjusted waist index (TyG-WWI): the best predictor of diabetes mellitus and mortality risks among TyG and TyG-derived indices","volume":"1","author":"Tu","year":"2025","journal-title":"BMC Endocr Disord"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.2196\/49617","article-title":"Metabolic score for insulin resistance and new-onset type 2 diabetes in a middle-aged and older adult population: Nationwide prospective cohort study and implications for primary care","volume":"10","author":"Cheng","year":"2024","journal-title":"JMIR Public Health Surveill"},{"key":"B25","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/s13098-025-01795-5","article-title":"Predictive value of obesity-related indices for incident type 2 diabetes mellitus: a longitudinal study of the Fukushima Health Database 2015-2021","volume":"1","author":"Ma","year":"2025","journal-title":"Diabetol Metab Syndr"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000044830","article-title":"Cholesterol-HDL-glucose index and type 2 diabetes risk in middle-aged and older adults: Evidence from a nationwide Chinese cohort","volume":"39","author":"Li","year":"2025","journal-title":"Med (Baltimore)"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26209888","article-title":"Relationship between insulin resistance indicators and type 2 diabetes mellitus in Romania","volume":"26","author":"\u015etefan","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B28","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1186\/s12933-025-02972-6","article-title":"Associations of longitudinal trajectories of triglyceride-glucose index combined with classical and novel obesity indices and cardiovascular disease: evidence from a nationwide prospective cohort study in China","volume":"1","author":"Wang","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12944-025-02836-8","article-title":"Comparison of the TyG index, TyG-traditional obesity indices, and TyG-novel obesity indices: does increased complexity help in predicting cardiometabolic multimorbidity","volume":"1","author":"Zhang","year":"2025","journal-title":"Lipids Health Dis"},{"key":"B30","doi-asserted-by":"publisher","first-page":"3301","DOI":"10.1186\/s12889-024-20631-5","article-title":"Evaluating a new obesity indicator for stroke risk prediction: comparative cohort analysis in rural settings of two nations","volume":"1","author":"Yao","year":"2024","journal-title":"BMC Public Health"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3390\/nu17030492","article-title":"The association between the triglyceride-glucose index, its combination with the body roundness index, and chronic kidney disease in patients with type 2 diabetes in Eastern China: a preliminary study","volume":"17","author":"Chen","year":"2025","journal-title":"Nutrients"},{"key":"B32","doi-asserted-by":"publisher","first-page":"10901","DOI":"10.1038\/s41598-024-61592-4","article-title":"Optimal obesity- and lipid-related indices for predicting type 2 diabetes in middle-aged and elderly Chinese","volume":"1","author":"Zhang","year":"2024","journal-title":"Sci Rep"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.102.1.42","article-title":"Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS)","volume":"1","author":"Festa","year":"2000","journal-title":"Circulation"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e98","DOI":"10.1016\/j.diabres.2011.05.030","article-title":"TyG index performs better than HOMA in a Brazilian population: a hyperglycemic clamp validated study","volume":"3","author":"Vasques","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcmed.2016.08.012","article-title":"Fasting triglycerides and glucose index as a diagnostic test for insulin resistance in young adults","volume":"5","author":"Guerrero-Romero","year":"2016","journal-title":"Arch Med Res"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-014-0146-3","article-title":"Clinical usefulness of lipid ratios, visceral adiposity indicators, and the triglycerides and glucose index as risk markers of insulin resistance","volume":"13","author":"Du","year":"2014","journal-title":"Cardiovasc Diabetol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"111315","DOI":"10.1016\/j.biopha.2021.111315","article-title":"Adipose tissue and insulin resistance in obese","volume":"137","author":"Ahmed","year":"2021","journal-title":"BioMed Pharmacother"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.53.12.3048","article-title":"Alterations in postprandial hepatic glycogen metabolism in type 2 diabetes","volume":"12","author":"Krssak","year":"2004","journal-title":"Diabetes"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.54.7.1942","article-title":"Obesity and type 2 diabetes impair insulin-induced suppression of glycogenolysis as well as gluconeogenesis","volume":"7","author":"Basu","year":"2005","journal-title":"Diabetes"},{"key":"B40","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cmet.2021.12.012","article-title":"Why does obesity cause diabetes","volume":"1","author":"Klein","year":"2022","journal-title":"Cell Metab"},{"key":"B41","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"6","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1111\/obr.12551","article-title":"Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation","volume":"7","author":"Bray","year":"2017","journal-title":"Obes Rev"},{"key":"B43","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1186\/s12889-018-5611-6","article-title":"Optimal cut-points of different anthropometric indices and their joint effect in prediction of type 2 diabetes: results of a cohort study","volume":"1","author":"Zafari","year":"2018","journal-title":"BMC Public Health"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-009266","article-title":"Anthropometric markers and their association with incident type 2 diabetes mellitus: which marker is best for prediction? Pooled analysis of four German population-based cohort studies and comparison with a nationwide cohort study","volume":"1","author":"Hartwig","year":"2016","journal-title":"BMJ Open"},{"key":"B45","doi-asserted-by":"publisher","first-page":"110932","DOI":"10.1016\/j.nut.2020.110932","article-title":"Is waist-to-height ratio a better predictor of hypertension and type 2 diabetes than body mass index and waist circumference in the Chilean population","author":"Petermann-Rocha","year":"2020","journal-title":"Nutrition"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(03)15268-3","article-title":"Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies","volume":"9403","year":"2004","journal-title":"Lancet"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30626","article-title":"Sex differences in nonalcoholic fatty liver disease: State of the art and identification of research gaps","volume":"4","author":"Lonardo","year":"2019","journal-title":"Hepatology"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3390\/metabo15110730","article-title":"Sex modifies metabolic pathways associated with lipids in untargeted metabolomics: The Coronary Artery Risk Development in Young Adults (CARDIA) Study, 2005-2006","volume":"15","author":"Hullings","year":"2025","journal-title":"Metabolites"},{"key":"B49","doi-asserted-by":"publisher","first-page":"7240063","DOI":"10.1155\/jobe\/7240063","article-title":"Sex-specific differences in visceral and subcutaneous adiposity accumulation and their association with metabolic abnormalities","volume":"2025","author":"Rodrigues","year":"2025","journal-title":"J Obes"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1805902\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:18:16Z","timestamp":1777609096000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1805902\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":49,"alternative-id":["10.3389\/fendo.2026.1805902"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1805902","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,1]]},"article-number":"1805902"}}